Epigenomic Disruption in Brain Cells Drives Alzheimer’s Cognitive Decline
TL;DR Summary
A large-scale study reveals that Alzheimer's disease involves fundamental breakdowns in epigenomic control within brain cells, leading to gene expression dysregulation and cognitive decline, suggesting new treatment avenues targeting genome stability.
- Alzheimer’s Linked to Epigenomic Breakdown, Not Just Plaques Neuroscience News
- Single-Cell Atlas Links Epigenomic Decline to Cognitive Loss Technology Networks
- When Brain Cells Lose Their Grip, Memory Follows ScienceBlog.com
- MIT Study Links Alzheimer’s Cognitive Decline to Disrupted Gene Regulation in Brain Cells geneonline.com
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
9 min
vs 10 min read
Condensed
98%
1,818 → 31 words
Want the full story? Read the original article
Read on Neuroscience News